IS4516A - Nýtt lyfjaform - Google Patents

Nýtt lyfjaform

Info

Publication number
IS4516A
IS4516A IS4516A IS4516A IS4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A IS 4516 A IS4516 A IS 4516A
Authority
IS
Iceland
Prior art keywords
pharmaceutical preparation
human
relates
pharmaceutical form
present
Prior art date
Application number
IS4516A
Other languages
English (en)
Inventor
Gizurarson Sveinbjörn
Original Assignee
Gizurarson Sveinbjörn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gizurarson Sveinbjörn filed Critical Gizurarson Sveinbjörn
Priority to IS4516A priority Critical patent/IS4516A/is
Priority to ES98930657T priority patent/ES2255165T3/es
Priority to CA002298596A priority patent/CA2298596A1/en
Priority to AU81022/98A priority patent/AU739893B2/en
Priority to EP98930657A priority patent/EP0991479B1/en
Priority to DK98930657T priority patent/DK0991479T3/da
Priority to US09/446,931 priority patent/US6647980B1/en
Priority to DE69832070T priority patent/DE69832070T2/de
Priority to PCT/DK1998/000297 priority patent/WO1999001229A1/en
Priority to AT98930657T priority patent/ATE307676T1/de
Publication of IS4516A publication Critical patent/IS4516A/is

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4516A 1997-07-01 1997-07-01 Nýtt lyfjaform IS4516A (is)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
AT98930657T ATE307676T1 (de) 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region
EP98930657A EP0991479B1 (en) 1997-07-01 1998-07-01 An administration package unit for the delivery to the olfactory region
CA002298596A CA2298596A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
AU81022/98A AU739893B2 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region
ES98930657T ES2255165T3 (es) 1997-07-01 1998-07-01 Unidad de envase de administracion para el suministro a la region olfativa.
DK98930657T DK0991479T3 (da) 1997-07-01 1998-07-01 Pakningsenhed til indgivelse til lugteområdet
US09/446,931 US6647980B1 (en) 1997-07-01 1998-07-01 Method for administration of active substances to the olfactory region
DE69832070T DE69832070T2 (de) 1997-07-01 1998-07-01 Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Publications (1)

Publication Number Publication Date
IS4516A true IS4516A (is) 1999-01-02

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Country Status (10)

Country Link
US (1) US6647980B1 (is)
EP (1) EP0991479B1 (is)
AT (1) ATE307676T1 (is)
AU (1) AU739893B2 (is)
CA (1) CA2298596A1 (is)
DE (1) DE69832070T2 (is)
DK (1) DK0991479T3 (is)
ES (1) ES2255165T3 (is)
IS (1) IS4516A (is)
WO (1) WO1999001229A1 (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7465287B2 (en) * 2001-02-08 2008-12-16 Nasaleze Patents Limited Apparatus for dispensing powdered material
CN1642576A (zh) * 2002-02-25 2005-07-20 药物发展有限公司 吸收增强剂
CN100528257C (zh) 2002-05-09 2009-08-19 葛兰素集团有限公司 流体分配设备
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
WO2005016273A2 (en) 2003-08-05 2005-02-24 3M Innovative Properties Company Infection prophylaxis using immune response modifier compounds
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
ES2388434T3 (es) 2003-11-03 2012-10-15 Glaxo Group Limited Dispositivo de administración de fluido
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
EP1960022A1 (en) * 2005-11-29 2008-08-27 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
US10478574B2 (en) * 2006-01-19 2019-11-19 Optinose As Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
CN101662935A (zh) * 2007-05-04 2010-03-03 宝洁公司 抗微生物组合物、产品以及使用方法
CN101980738A (zh) * 2008-02-07 2011-02-23 华盛顿大学 圆周气雾设备
WO2010134804A1 (en) 2009-05-19 2010-11-25 Lerner Eduard N Device and methods for enhanced multi-delivery of biologically active substances into an organism and to prevent local irritation
EP3679971B1 (en) 2011-03-03 2022-07-27 Impel Pharmaceuticals Inc. Nasal drug delivery device
AU2012253569B2 (en) 2011-05-09 2018-02-15 Impel Pharmaceuticals Inc. Nozzles for nasal drug delivery
WO2014179228A1 (en) 2013-04-28 2014-11-06 Impel Neuropharma Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
KR20180052662A (ko) 2015-09-10 2018-05-18 임펠 뉴로파마 인코포레이티드 인-라인 코 전달 장치
US11571532B2 (en) 2017-11-21 2023-02-07 Impel Pharmaceuticals Inc. Intranasal device with dip tube
WO2019104192A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
CA3087698A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
ES2937440T3 (es) 2018-01-05 2023-03-28 Impel Pharmaceuticals Inc Administración intranasal de dihidroergotamina mediante un dispositivo olfativo de precisión
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
AU2019418744B2 (en) 2019-01-03 2023-08-03 Impel Pharmaceuticals Inc. Nasal drug delivery device
KR20220010011A (ko) 2019-05-17 2022-01-25 임펠 뉴로파마 인코포레이티드 일회용 비강 전달 장치
AU2020345050A1 (en) * 2019-09-13 2021-09-16 Janssen Pharmaceuticals, Inc. Intranasal administration of esketamine
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
CH539556A (de) 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
AU6909091A (en) 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
AU7669496A (en) 1995-11-03 1997-05-22 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
WO1999001229A1 (en) 1999-01-14
ATE307676T1 (de) 2005-11-15
AU739893B2 (en) 2001-10-25
EP0991479A1 (en) 2000-04-12
ES2255165T3 (es) 2006-06-16
US6647980B1 (en) 2003-11-18
AU8102298A (en) 1999-01-25
DE69832070D1 (de) 2005-12-01
DE69832070T2 (de) 2006-07-13
CA2298596A1 (en) 1999-01-14
DK0991479T3 (da) 2006-03-13
EP0991479B1 (en) 2005-10-26

Similar Documents

Publication Publication Date Title
IS4516A (is) Nýtt lyfjaform
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
ATE195249T1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
DE69329400D1 (de) L-Dopa Ester enthaltende Zusammensetzung
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
BR0316685A (pt) Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade
DK0630230T3 (da) Farmaceutiske inhaleringspræparater
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
WO1999020244A3 (de) Verfahren zur transdermalen applikation von wirkstoffen in hoher, konstanter dosierung
MY117960A (en) A new salt
KR930019224A (ko) 유산 위험 치료제
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
RU94045433A (ru) Устройство для проведения воздушно-аэрозольных ванн из минеральной воды и лекарственных препаратов
RU97116821A (ru) Способ лечения респираторных заболеваний